ES449941A1 - Un metodo de preparacion de un nuevo virus vivo de la rabia. - Google Patents

Un metodo de preparacion de un nuevo virus vivo de la rabia.

Info

Publication number
ES449941A1
ES449941A1 ES449941A ES449941A ES449941A1 ES 449941 A1 ES449941 A1 ES 449941A1 ES 449941 A ES449941 A ES 449941A ES 449941 A ES449941 A ES 449941A ES 449941 A1 ES449941 A1 ES 449941A1
Authority
ES
Spain
Prior art keywords
rabies virus
virus vaccine
processes
novel
novel rabies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES449941A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips Roxane Inc
Original Assignee
Philips Roxane Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane Inc filed Critical Philips Roxane Inc
Publication of ES449941A1 publication Critical patent/ES449941A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES449941A 1975-07-21 1976-07-19 Un metodo de preparacion de un nuevo virus vivo de la rabia. Expired ES449941A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/597,654 US4040904A (en) 1975-07-21 1975-07-21 Novel rabies virus vaccine and processes

Publications (1)

Publication Number Publication Date
ES449941A1 true ES449941A1 (es) 1977-07-01

Family

ID=24392406

Family Applications (1)

Application Number Title Priority Date Filing Date
ES449941A Expired ES449941A1 (es) 1975-07-21 1976-07-19 Un metodo de preparacion de un nuevo virus vivo de la rabia.

Country Status (15)

Country Link
US (1) US4040904A (es)
JP (1) JPS5218814A (es)
AT (1) AT345450B (es)
AU (1) AU1606576A (es)
BE (1) BE844353A (es)
DE (1) DE2632255A1 (es)
DK (1) DK323276A (es)
ES (1) ES449941A1 (es)
FR (1) FR2318652A1 (es)
GB (1) GB1551437A (es)
IT (1) IT1062543B (es)
NL (1) NL7607958A (es)
NZ (1) NZ181498A (es)
SE (1) SE7608206L (es)
ZA (1) ZA764124B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
US4726946A (en) * 1980-07-30 1988-02-23 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4347239A (en) * 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
US4584194A (en) * 1980-07-30 1986-04-22 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
CA1249518A (en) * 1985-09-06 1989-01-31 David Johnston Oral immunization of mammals
JP2667745B2 (ja) * 1991-03-11 1997-10-27 シャープ株式会社 電気音響変換器
EP1945780B1 (en) * 2005-10-14 2015-09-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Rabies virus vector systems and compositions and methods thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof

Also Published As

Publication number Publication date
JPS5218814A (en) 1977-02-12
AU1606576A (en) 1978-01-26
ZA764124B (en) 1978-02-22
SE7608206L (sv) 1977-01-22
GB1551437A (en) 1979-08-30
BE844353A (fr) 1977-01-20
DK323276A (da) 1977-01-22
IT1062543B (it) 1984-10-20
NL7607958A (nl) 1977-01-25
ATA530876A (de) 1978-01-15
FR2318652A1 (fr) 1977-02-18
NZ181498A (en) 1978-06-02
US4040904A (en) 1977-08-09
DE2632255A1 (de) 1977-02-17
AT345450B (de) 1978-09-11

Similar Documents

Publication Publication Date Title
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
DK401981A (da) Herpes simplex type 1 underenhed vaccine og fremgangsmaade til fremstilling deraf
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
JPS5290620A (en) Novel medicine for treating acute or chronic infection by hepatisis virus b
JPS51133414A (en) Production of vaccine against viral hepatisis
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
ES476703A1 (es) Procedimiento para preparar una heterovacuna para el trata -miento terapeutico del sindrome de los triconomas.
CH611338A5 (en) Process for the preparation of inactivated HB-Ag vaccines
FR2261779A1 (en) Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
NO147488C (no) Fremgangsmaate for opparbeidelse av syretjaere ved noeytralisering og pyrolyse.
JPS5231266A (en) Fixing method of stud-bolt for rake booster body
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
NL7506620A (en) Cell-free chickenpox virus prodn - for vaccines, by passing on human or monkey cells until attenuated then recovering the virus in presence of a stabiliser
FR2310772A1 (fr) Vaccin contre la varicelle et procede pour sa preparation
FR2331354A2 (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
ES476147A1 (es) Un metodo de obtencion de un complejo inmunogenico antigeni-co
OA00849A (fr) Procédé de préparation d'un vaccin contre le trachome.
BE842796A (fr) Procede de preparation de vaccins de virus
AU216361B2 (en) Poliomyelitis virus vaccine and method of producing thesame
PH13837A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
AU505075B2 (en) Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
AU1668156A (en) Poliomyelitis virus vaccine and method of producing thesame
AU160609B2 (en) Improvements relating tothe production of poliomyelitis virus vaccine